FDA NDC Directory · JSON-LD · Markdown

Tembexa

NDC 64678-012 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameBrincidofovir
Labeler / ManufacturerEmergent BioDefense Operations Lansing LLC
Marketing categoryNew Drug Application (innovator) · App NDA214460
Dosage form / routeSUSPENSION · ORAL
Active ingredientsBRINCIDOFOVIR (10 mg/mL)
Marketing started20220420
Package count4

External sources

Source: openFDA. Public-domain (CC0).